In 2019, the US Food and Drug Administration (FDA) approved 48 novel drugs. Thirty of the 48 (62.5%) novel drug approvals were reviewed and approved through an expedited review pathway while 20 of the 48 (41.7%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2019.Copyright © 2020 Elsevier Inc.
CITATION STYLE
Sears, E. (2008). New Drugs Approved in 2007. Baylor University Medical Center Proceedings, 21(2), 186–191. https://doi.org/10.1080/08998280.2008.11928391
Mendeley helps you to discover research relevant for your work.